Author

Qian Xu

Nanjing Medical UniversityORCID 0009-0002-2382-4523Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Qian Xu6 papers · Texas A&M University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Fan LiniD· 1 shared Haiyang WangiD· 1 shared Hanyang YuiD· 1 shared Jing WangiD· 1 shared Liu Yang· 1 shared Mingde HuangiD· 1 shared Pingping CaoiD· 1 shared Qianghu WangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Fan LinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 15, 2024

Oncogene-induced senescence and senescence-associated secretory phenotype (SASP) determine the efficacy of palbociclib in PIK3CA mutated colorectal cancer

Pingping Cao, Xiaohui Zhou, Suisui Yang…·Fan Lin

This study shows that PIK3CA mutations in colorectal cancer induce senescence and SASP, causing resistance to palbociclib, but combining it with erlotinib overcomes this resistance.

DOI 10.1101/2024.11.15.623304

humanexperimental assay

𝕏 PostBluesky